Robert Putnak

2.5k total citations
39 papers, 2.0k citations indexed

About

Robert Putnak is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robert Putnak has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Public Health, Environmental and Occupational Health, 31 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Robert Putnak's work include Mosquito-borne diseases and control (38 papers), Viral Infections and Vectors (24 papers) and Malaria Research and Control (16 papers). Robert Putnak is often cited by papers focused on Mosquito-borne diseases and control (38 papers), Viral Infections and Vectors (24 papers) and Malaria Research and Control (16 papers). Robert Putnak collaborates with scholars based in United States, Thailand and South Korea. Robert Putnak's co-authors include Kenneth H. Eckels, David W. Vaughn, R. Padmanabhan, Bruce L. Innis, Wellington Sun, Stephen J. Thomas, Monika Simmons, Prem Mohan, Yasuyuki Sasaguri and Robert V. Gibbons and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Robert Putnak

39 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Putnak United States 25 1.8k 1.6k 223 166 136 39 2.0k
J. Robert Putnak United States 25 2.0k 1.1× 1.8k 1.1× 257 1.2× 174 1.0× 132 1.0× 36 2.4k
Mayling Álvarez Cuba 28 2.2k 1.2× 1.8k 1.1× 186 0.8× 135 0.8× 129 0.9× 65 2.4k
Niranjan Kanesa-thasan United States 25 1.7k 0.9× 1.6k 1.0× 353 1.6× 135 0.8× 143 1.1× 44 2.2k
Kriengsak Limkittikul Thailand 21 1.7k 0.9× 1.2k 0.7× 219 1.0× 138 0.8× 108 0.8× 66 2.0k
Hugues Tolou France 27 2.5k 1.4× 2.1k 1.3× 257 1.2× 220 1.3× 173 1.3× 64 2.9k
Bruce C. Cropp United States 20 1.8k 1.0× 1.7k 1.1× 222 1.0× 137 0.8× 63 0.5× 21 2.1k
Juan Arroyo United States 18 1.7k 0.9× 1.6k 1.0× 211 0.9× 173 1.0× 108 0.8× 20 1.9k
C. H. Hoke United States 25 1.9k 1.0× 1.7k 1.1× 290 1.3× 128 0.8× 162 1.2× 34 2.2k
Christophe N. Peyrefitte France 26 1.5k 0.8× 1.4k 0.9× 295 1.3× 141 0.8× 203 1.5× 64 2.1k
Jorge Bóshell Colombia 13 1.3k 0.7× 1.0k 0.6× 202 0.9× 103 0.6× 139 1.0× 26 1.5k

Countries citing papers authored by Robert Putnak

Since Specialization
Citations

This map shows the geographic impact of Robert Putnak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Putnak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Putnak more than expected).

Fields of papers citing papers by Robert Putnak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Putnak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Putnak. The network helps show where Robert Putnak may publish in the future.

Co-authorship network of co-authors of Robert Putnak

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Putnak. A scholar is included among the top collaborators of Robert Putnak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Putnak. Robert Putnak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simmons, Monika, Peifang Sun, & Robert Putnak. (2016). Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine. PLoS ONE. 11(4). e0152811–e0152811. 13 indexed citations
2.
Liu, Ge, Langzhou Song, David W. C. Beasley, et al.. (2015). Immunogenicity and Efficacy of Flagellin-Envelope Fusion Dengue Vaccines in Mice and Monkeys. Clinical and Vaccine Immunology. 22(5). 516–525. 22 indexed citations
3.
Ramsauer, Katrin, Michael Schwameis, Christa Firbas, et al.. (2015). Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial. The Lancet Infectious Diseases. 15(5). 519–527. 170 indexed citations
4.
Eick-Cost, Angelia A, Zheng Hu, Terry A. Klein, Robert Putnak, & Richard G. Jarman. (2015). Seroconversion to Japanese Encephalitis Virus Among U.S. Infantry Forces in Korea. American Journal of Tropical Medicine and Hygiene. 93(5). 1052–1054. 5 indexed citations
5.
Gibbons, Robert V., Robert Edelman, Kenneth H. Eckels, et al.. (2011). Interference and Facilitation Between Dengue Serotypes in a Tetravalent Live Dengue Virus Vaccine Candidate. The Journal of Infectious Diseases. 204(3). 442–450. 43 indexed citations
6.
Gessel, Yvonne Van, Christoph Klade, Robert Putnak, et al.. (2011). Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers. Vaccine. 29(35). 5925–5931. 83 indexed citations
7.
Putnak, Robert, Kenneth H. Eckels, M. P. Mammen, et al.. (2011). A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine. 29(22). 3895–3904. 89 indexed citations
8.
Tang, Yuxin, Prinyada Rodpradit, Piyawan Chinnawirotpisan, et al.. (2010). Comparative Analysis of Full-Length Genomic Sequences of 10 Dengue Serotype 1 Viruses Associated with Different Genotypes, Epidemics, and Disease Severity Isolated in Thailand over 22 Years. American Journal of Tropical Medicine and Hygiene. 83(5). 1156–1165. 16 indexed citations
10.
Simmons, Monika, Timothy Burgess, Julia Lynch, & Robert Putnak. (2009). Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy. Virology. 396(2). 280–288. 79 indexed citations
11.
Takhampunya, Ratree, Dupeh R. Palmer, Julia Lynch, et al.. (2009). Phenotypic analysis of dengue virus isolates associated with dengue fever and dengue hemorrhagic fever for cellular attachment, replication and interferon signaling ability. Virus Research. 145(1). 31–38. 8 indexed citations
12.
Lyons, Arthur, Niranjan Kanesa-thasan, Robert A. Kuschner, et al.. (2007). A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis. Vaccine. 25(17). 3445–3453. 47 indexed citations
13.
Putnak, Robert, Kevin R. Porter, & Connie S. Schmaljohn. (2003). DNA Vaccines for Flaviviruses. Advances in virus research. 61. 445–468. 33 indexed citations
14.
Hong, Sun Pyo, Wangdon Yoo, Robert Putnak, et al.. (2001). Nucleotide Sequence of Envelope Protein of Japanese Encephalitis Virus SA14-14-2 Adapted to Vero Cells. DNA sequence. 12(5-6). 437–442. 5 indexed citations
15.
Putnak, Robert, N. Conforti, Rebecca Lee, et al.. (1996). Immunogenic and Protective Response in Mice Immunized with a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype Made in Fetal Rhesus Lung Cells. American Journal of Tropical Medicine and Hygiene. 55(5). 504–510. 44 indexed citations
16.
Rothwell, Stephen W., Robert Putnak, & Vincent F. La Russa. (1996). Dengue-2 Virus Infection of Human Bone Marrow: Characterization of Dengue-2 Antigen-Positive Stromal Cells. American Journal of Tropical Medicine and Hygiene. 54(5). 503–510. 49 indexed citations
17.
Putnak, Robert, D R Dubois, Vito D’Andrea, et al.. (1996). Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys. The Journal of Infectious Diseases. 174(6). 1176–1184. 137 indexed citations
18.
Feighny, Robert J., et al.. (1994). Dengue Type-2 Virus Envelope Protein Made Using Recombinant Baculovirus Protects Mice against Virus Challenge. American Journal of Tropical Medicine and Hygiene. 50(3). 322–328. 24 indexed citations
19.
Putnak, Robert, Robert J. Feighny, Mark D. Cochran, et al.. (1991). Dengue-1 Virus Envelope Glycoprotein Gene Expressed in Recombinant Baculovirus Elicits Virus-Neutralizing Antibody in Mice and Protects them from Virus Challenge. American Journal of Tropical Medicine and Hygiene. 45(2). 159–167. 45 indexed citations
20.
McCown, J. M., Mark D. Cochran, Robert Putnak, et al.. (1990). Protection of Mice Against Lethal Japanese Encephalitis with a Recombinant Baculovirus Vaccine. American Journal of Tropical Medicine and Hygiene. 42(5). 491–499. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026